Dr. Michael Weiss (University of Washington) provided an overview of the results of the now completed clinical trial of Mexiletine in patients with sporadic ALS (non-familial).
Dr. Michael Weiss (University of Washington) provided an overview of the results of the now completed clinical trial of Mexiletine in patients with sporadic ALS (non-familial).